Related Experiment Video
Updated: Jun 21, 2026

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Targeting of the protein interaction site between FAK and IGF-1R
Donghang Zheng1, Elena Kurenova, Deniz Ucar
1Department of Surgery, University of Florida, Gainesville, FL, USA.
Abstract:
The interaction of focal adhesion kinase (FAK) and insulin-like growth factor-1 receptor (IGF-1R) plays an important role in cancer cell survival. Targeting this interaction with small molecule drugs could be a novel strategy in cancer therapy. By a series of pull-down assays using GST-tagged FAK fragments and His-tagged IGF-1R intracellular fragments, we showed that the FAK-NT2 (a.a. 127-243) domain directly interacts with the N-terminal part of the IGF-1R intracellular domain. Overexpressed FAK-NT2 domain was also shown to co-localize with IGF-1R in pancreatic cells. Computational modeling was used to predict the binding configuration of these two domains and to screen for small molecules binding to the interaction site. This strategy successfully identified a lead compound that disrupts FAK/IGF-1R interaction.
Insights
Researchers identified a key interaction between focal adhesion kinase (FAK) and insulin-like growth factor-1 receptor (IGF-1R) crucial for cancer cell survival. A novel compound was discovered that disrupts this FAK/IGF-1R binding, offering a potential new cancer therapy strategy.
Area of Science:
- Molecular biology
- Cancer research
- Drug discovery
Background:
- The interaction between focal adhesion kinase (FAK) and insulin-like growth factor-1 receptor (IGF-1R) is vital for cancer cell survival.
- Targeting this interaction presents a novel therapeutic strategy for cancer treatment.
Purpose of the Study:
- To elucidate the specific domains involved in FAK and IGF-1R interaction.
- To identify small molecules capable of disrupting the FAK/IGF-1R binding site.
Main Methods:
- Pull-down assays using GST-tagged FAK fragments and His-tagged IGF-1R intracellular fragments.
- Co-localization studies in pancreatic cells with overexpressed FAK-NT2 domain.
- Computational modeling for predicting binding configurations and screening small molecules.
Main Results:
- The FAK-NT2 (amino acids 127-243) domain directly interacts with the N-terminal region of the IGF-1R intracellular domain.
- FAK-NT2 domain co-localizes with IGF-1R in pancreatic cells.
- A lead compound was identified that effectively disrupts the FAK/IGF-1R interaction.
Conclusions:
- The FAK-NT2 domain is a critical interaction site with IGF-1R.
- Small molecule-based disruption of the FAK/IGF-1R interaction is a viable therapeutic approach.
- The identified lead compound shows promise for developing new anti-cancer drugs targeting this pathway.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

